| Metric | Oct 30, 2024 FY24 Q3 | Feb 6, 2025 FY24 Q4 | May 5, 2025 FY25 Q1 | Aug 7, 2025 FY25 Q2 | Nov 5, 2025 FY25 Q3 | Feb 10, 2026 FY25 Q4 | Apr 28, 2026 FY26 Q1 | Aug 5, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Constant Currency Revenue Change | — | — | — | — | — | New“2.0% - 4.0%” | Reiterated“2.0% - 4.0%” | Raised“3.4% - 4.4%” |
| Organic Constant Currency Revenue Change (1) | — | — | — | — | — | New“1.0% - 3.0%” | Reiterated“1.0% - 3.0%” | Raised“2.25% - 3.25%” |
| Adjusted Diluted EPS (2) | — | — | — | — | — | New“$8.30 - $8.45” | Raised“$8.40 - $8.55” | Raised“$8.47 - $8.59” |
| Foreign Currency Exchange Impact | — | — | — | — | — | New“+0.50%” | Reiterated“+0.5%” | Reiterated“+0.5%” |
| Share repurchase expectations | — | — | — | — | — | — | — | New“up to $1 billion of its common stock” |
| For FY2025 | ||||||||
| Constant Currency Revenue Change | — | New“3.0% - 5.0%” | Raised“5.7% - 7.7%” | — | Narrowed“6.2% - 6.7%” | — | — | — |
| Constant currency revenue growth | — | — | — | New“6.2% - 7.2%” | — | — | — | — |
| Organic Constant Currency Revenue Change (1) | — | — | New“3.0% - 5.0%” | — | Narrowed“3.5% - 4.0%” | — | — | — |
| Organic constant currency revenue growth | — | — | — | New“3.5% - 4.5%” | — | — | — | — |
| Reported revenue growth | — | — | — | New“6.7% - 7.7%” | — | — | — | — |
| Adjusted Diluted EPS | — | New“$8.15 - $8.35” | — | — | — | — | — | — |
| Adjusted Diluted EPS (2) | — | — | New“$7.90 - $8.10” | Raised“$8.10 - $8.30” | Reiterated“$8.10 - $8.30” | — | — | — |
| Adjusted earnings per share financial | — | — | — | New“$8.10 - $8.30” | — | — | — | — |
| Foreign Currency Exchange Impact | — | New“(2.0)% - (1.5)%” | Raised“0.0% - 0.5%” | Raised“0.5%” | Raised“0.5% - 1.0%” | — | — | — |
| For FY2024 | ||||||||
| Constant Currency Revenue Change | New“4.25% - 4.75%” | — | — | — | — | — | — | — |
| Adjusted Diluted EPS | New“$7.95 - $8.05” | — | — | — | — | — | — | — |
| Foreign Currency Exchange Impact | New“(0.75)%” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Stock repurchase authorization | — | — | — | — | — | New“up to $1.5 billion in common stock” | — | — |